Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources
- DOI
- 10.1016/s2352-3026(25)00320-5
- Published
- 2026-01
- Container
- The Lancet Haematology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2352-3026-25-00320-5,
title = {Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources},
author = {Khaled M Musallam and Sujit Sheth and Maria Domenica Cappellini and Farrukh Shah and Stefano Rivella and Vijay G Sankaran and Kevin H M Kuo and Vip Viprakasit and Androulla Eleftheriou and Michael Angastiniotis and Franco Locatelli and Ali T Taher},
year = {2026},
journal = {The Lancet Haematology},
doi = {10.1016/s2352-3026(25)00320-5},
url = {https://doi.org/10.1016/s2352-3026(25)00320-5}
}RIS
TY - JOUR TI - Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources AU - Khaled M Musallam AU - Sujit Sheth AU - Maria Domenica Cappellini AU - Farrukh Shah AU - Stefano Rivella AU - Vijay G Sankaran AU - Kevin H M Kuo AU - Vip Viprakasit AU - Androulla Eleftheriou AU - Michael Angastiniotis AU - Franco Locatelli AU - Ali T Taher PY - 2026 JO - The Lancet Haematology DO - 10.1016/s2352-3026(25)00320-5 UR - https://doi.org/10.1016/s2352-3026(25)00320-5 ER -
APA
Musallam, K. M., Sheth, S., Cappellini, M. D., Shah, F., Rivella, S., Sankaran, V. G., Kuo, K. H. M., Viprakasit, V., Eleftheriou, A., Angastiniotis, M., Locatelli, F., & Taher, A. T. (2026). Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(25)00320-5
Source records
- crossref · retrieved 2026-09-26T01:30:26.122Z